Cargando…

Sacral Neuromodulation in Patients With a Cardiac Pacemaker

The objective of this study was to describe our experience using sacral neuromodulation to treat urinary urgency, frequency, urge incontinence, and chronic urinary retention in patients with cardiac pacemakers. With the increasingly widespread use of InterStim for bladder function restoration, we ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Gahzi, Abdullah A., Elterman, Dean S., Hassouna, Magdy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Continence Society 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083830/
https://www.ncbi.nlm.nih.gov/pubmed/27706012
http://dx.doi.org/10.5213/inj.1632536.268
_version_ 1782463290784350208
author Gahzi, Abdullah A.
Elterman, Dean S.
Hassouna, Magdy
author_facet Gahzi, Abdullah A.
Elterman, Dean S.
Hassouna, Magdy
author_sort Gahzi, Abdullah A.
collection PubMed
description The objective of this study was to describe our experience using sacral neuromodulation to treat urinary urgency, frequency, urge incontinence, and chronic urinary retention in patients with cardiac pacemakers. With the increasingly widespread use of InterStim for bladder function restoration, we are seeing more complex patients with multiple comorbidities, including cardiac conditions. Herein, we report 3 cases of individuals with cardiac pacemakers who underwent InterStim implantation to treat urinary conditions. This study is a case series of 3 patients with cardiac pacemakers who underwent sacral neuromodulation to treat refractory voiding dysfunction. The initial patient screening for InterStim therapy involved percutaneous nerve evaluation (PNE), in which a temporary untined lead wire was placed through the S3 foramen. Patients who did not respond to PNE proceeded to a staged implant. All patients in this study had a greater than 50% improvement of their urinary symptoms during the initial trial and underwent placement of the InterStim implantable pulse generator (IPG). Postoperative programming was done under electrocardiogram monitoring by a cardiologist. No interference was observed between the Inter-Stim IPG and the cardiac pacemaker. In this group of patients, sacral neuromodulation in the presence of a cardiac pacemaker appears to have been safe.
format Online
Article
Text
id pubmed-5083830
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Korean Continence Society
record_format MEDLINE/PubMed
spelling pubmed-50838302016-11-01 Sacral Neuromodulation in Patients With a Cardiac Pacemaker Gahzi, Abdullah A. Elterman, Dean S. Hassouna, Magdy Int Neurourol J Case Report The objective of this study was to describe our experience using sacral neuromodulation to treat urinary urgency, frequency, urge incontinence, and chronic urinary retention in patients with cardiac pacemakers. With the increasingly widespread use of InterStim for bladder function restoration, we are seeing more complex patients with multiple comorbidities, including cardiac conditions. Herein, we report 3 cases of individuals with cardiac pacemakers who underwent InterStim implantation to treat urinary conditions. This study is a case series of 3 patients with cardiac pacemakers who underwent sacral neuromodulation to treat refractory voiding dysfunction. The initial patient screening for InterStim therapy involved percutaneous nerve evaluation (PNE), in which a temporary untined lead wire was placed through the S3 foramen. Patients who did not respond to PNE proceeded to a staged implant. All patients in this study had a greater than 50% improvement of their urinary symptoms during the initial trial and underwent placement of the InterStim implantable pulse generator (IPG). Postoperative programming was done under electrocardiogram monitoring by a cardiologist. No interference was observed between the Inter-Stim IPG and the cardiac pacemaker. In this group of patients, sacral neuromodulation in the presence of a cardiac pacemaker appears to have been safe. Korean Continence Society 2016-09 2016-09-23 /pmc/articles/PMC5083830/ /pubmed/27706012 http://dx.doi.org/10.5213/inj.1632536.268 Text en Copyright © 2016 Korean Continence Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Gahzi, Abdullah A.
Elterman, Dean S.
Hassouna, Magdy
Sacral Neuromodulation in Patients With a Cardiac Pacemaker
title Sacral Neuromodulation in Patients With a Cardiac Pacemaker
title_full Sacral Neuromodulation in Patients With a Cardiac Pacemaker
title_fullStr Sacral Neuromodulation in Patients With a Cardiac Pacemaker
title_full_unstemmed Sacral Neuromodulation in Patients With a Cardiac Pacemaker
title_short Sacral Neuromodulation in Patients With a Cardiac Pacemaker
title_sort sacral neuromodulation in patients with a cardiac pacemaker
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083830/
https://www.ncbi.nlm.nih.gov/pubmed/27706012
http://dx.doi.org/10.5213/inj.1632536.268
work_keys_str_mv AT gahziabdullaha sacralneuromodulationinpatientswithacardiacpacemaker
AT eltermandeans sacralneuromodulationinpatientswithacardiacpacemaker
AT hassounamagdy sacralneuromodulationinpatientswithacardiacpacemaker